Related Experiment Video
Updated: May 22, 2026
06:49
Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
Published on: December 17, 2021
Are long-range structural correlations behind the aggregration phenomena of polyglutamine diseases?
Mahmoud Moradi1, Volodymyr Babin, Christopher Roland
1Center for High Performance Simulations (CHiPS) and Department of Physics, North Carolina State University, Raleigh, North Carolina, USA.
Plos Computational Biology
|May 12, 2012
Summary
Long-range correlations in polyglutamine (Qn) peptides, especially Q40, promote aggregation by enabling extended structures. A polyproline sequence reduces these aggregation-prone features.
Area of Science:
- Biophysics
- Computational Chemistry
- Molecular Biology
Background:
- Polyglutamine (Qn) peptides are implicated in neurodegenerative diseases like Huntington's disease.
- Understanding the conformational dynamics of Qn peptides is crucial for disease mechanism elucidation.
Purpose of the Study:
- To characterize the conformational ensembles of polyglutamine peptides of varying lengths.
- To investigate the role of long-range correlations and secondary structures in Qn aggregation.
- To assess the impact of a C-terminal polyproline sequence on Qn conformations.
Main Methods:
- Advanced molecular dynamics (MD) simulations.
- Novel statistical analysis of backbone dihedral angles.
- Characterization of secondary structural motifs (α-helices, β-strands, turns, hairpins).
Main Results:
- Q40 peptides exhibit disordered, compact conformations with some α-helical and turn content.
- A small population of extended structures (β- and α-strands/hairpins) capable of aggregation was identified in Q40.
- Long-range correlations (≥20 residues) in dihedral angles were observed in Q40, absent in shorter peptides.
- A C-terminal hexaproline motif reduced aggregation-prone structures and long-range correlations in Q40.
Conclusions:
- Long-range backbone correlations and extended structures in polyglutamine peptides, particularly Q40, are key factors in aggregation.
- The presence of these features above the pathological length threshold (≃36) suggests a mechanism for disease initiation.
- Polyproline sequences may act as modulators of polyglutamine aggregation by disrupting these critical conformational properties.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:13Protein Organization
Overview